Clinical Trial Update: Combined Approach to Resection of Glioblastoma (GBM) by 5-Aminolevulinic Acid (5-ALA) and Intraoperative Magnetic Resonance Imaging (MRI)

View source ↗

Summary

Clinical trial update from the University of Zurich evaluating a combined approach to glioblastoma resection using 5-ALA fluorescence and intraoperative MRI to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• 5-aminolevulinic acid (5-ALA) (5-aminolevulinic acid)

Snippet

Sponsor: University of Zurich | Conditions: Glioblastoma | Status: UNKNOWN